Most cancer drugs must now be tested in paediatric cancers — unique PDX models can help

Approximately 75% of anticancer drugs must be tested against paediatric cancer. Drug developers can now use a database of patient-derived tumour models to screen their products for paediatric cancer indications.

Read more: https://www.nature.com/articles/d42473-024-00172-6